Sitoiganap — Now Available in Kosovo for Eligible Glioblastoma Patients.
The first immunotherapy for Glioblastoma Multiforme to receive full governmental authorization and public healthcare reimbursement.
Developed by ERC. Coordinated by Pharmabel.
What Is Sitoiganap?
Sitoiganap (Gliovac / ERC1671) is a therapeutic cancer vaccine developed by ERC — Epitopoietic Research Corporation. It uses a unique combination of autologous and allogeneic tumour cells and lysates to stimulate the patient’s own immune system to recognize and attack glioma cells.
Unlike conventional approaches, Sitoiganap works with the body’s natural defenses — not against them.
The Ministry of Health of the Republic of Kosovo has officially authorized the use of Sitoiganap for Glioblastoma Multiforme, with full public healthcare reimbursement under standard procedures. No exceptional conditions. No restrictions.
This is a first — worldwide.
What to Expect — The Patient Journey
We built this program so that neither the patient nor the referring physician has to worry about logistics. Every step is managed.
01 — Airport Welcome Personal reception at Pristina International Airport. Private transfer to your accommodation.
02 — Medical Consultation In-depth review of the patient’s file with Dr. Armend Kerveshi and his neurosurgical team at the Royal Hospital of Pristina. Treatment plan established.
03 — Premium Accommodation Stay at one of our 5-star partner hotels with spa access, for the full duration of the treatment period.
04 — Treatment Sessions Accompanied transport to and from each session. The patient is never alone.
05 — 24/7 Medical Hotline A dedicated medical support line is available at all times during the patient’s stay.
06 — Interpreter Service Professional interpreters available in the patient’s and family’s language, to ensure clear communication at every medical step.
07 — Departure & Continuity of Care Transfer to the airport. Complete medical documentation provided for seamless follow-up with the referring physician.
Your Medical Team in Pristina
Dr. Armend Kerveshi Lead Neurosurgeon — Royal Hospital of Pristina, Kosovo
Dr. Kerveshi leads the medical team responsible for all Sitoiganap patients. Every treatment plan is supervised, reviewed, and coordinated under his direct authority.
Refer a patient
If you are a neurologist, neurosurgeon, or oncologist with a Glioblastoma patient who may benefit from Sitoiganap or if you are a patient or family member seeking options, we are here to help.
Contact us directly. We will coordinate the entire process in close collaboration with the referring medical team.
Julia Hababou Partner — Head of Strategy & Coordination [email protected]